Jing Wang , Siyi Wang , Jiahui Zhang, Dongsheng Ji, Zhi-Shu Huang, Ding Li
{"title":"Regulation of VEGF gene expression by bisacridine derivative through promoter i-motif for cancer treatment","authors":"Jing Wang , Siyi Wang , Jiahui Zhang, Dongsheng Ji, Zhi-Shu Huang, Ding Li","doi":"10.1016/j.bbagen.2024.130631","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Vascular endothelial growth factor (VEGF) is overexpressed in most malignant tumors, which has important impact on tumor angiogenesis and development. Its gene promoter i-motif structure formed by C-rich sequence can regulate gene expression, which is a promising new target for anti-tumor therapy.</p></div><div><h3>Methods</h3><p>We screened various compounds and studied their effects on VEGF through extensive experiments, including SPR, MST, TO displacement, FRET, CD, ESI-MS, NMR, MTT, clone formation, qPCR, Western blot, dual-luciferase reporter assay, immunofluorescence, cell scrape, apoptosis, transwell assay, and animal model.</p></div><div><h3>Results</h3><p>After extensive screening, bisacridine derivative <strong>B09</strong> was found to have selective binding and stabilization to VEGF promoter i-motif, which could down-regulate VEGF gene expression. <strong>B09</strong> showed potent inhibition on MCF-7 and HGC-27 cell proliferation and metastasis. <strong>B09</strong> significantly inhibited tumor growth in xenograft mice model with HGC-27 cells, showing decreased VEGF expression analyzed through immunohistochemistry.</p></div><div><h3>Conclusion</h3><p><strong>B09</strong> could specifically regulate VEGF gene expression, possibly through interacting with promoter i-motif structure. As a lead compound, <strong>B09</strong> could be further developed for innovative anti-cancer agent targeting VEGF.</p></div>","PeriodicalId":8800,"journal":{"name":"Biochimica et biophysica acta. General subjects","volume":"1868 7","pages":"Article 130631"},"PeriodicalIF":2.8000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et biophysica acta. General subjects","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304416524000746","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Vascular endothelial growth factor (VEGF) is overexpressed in most malignant tumors, which has important impact on tumor angiogenesis and development. Its gene promoter i-motif structure formed by C-rich sequence can regulate gene expression, which is a promising new target for anti-tumor therapy.
Methods
We screened various compounds and studied their effects on VEGF through extensive experiments, including SPR, MST, TO displacement, FRET, CD, ESI-MS, NMR, MTT, clone formation, qPCR, Western blot, dual-luciferase reporter assay, immunofluorescence, cell scrape, apoptosis, transwell assay, and animal model.
Results
After extensive screening, bisacridine derivative B09 was found to have selective binding and stabilization to VEGF promoter i-motif, which could down-regulate VEGF gene expression. B09 showed potent inhibition on MCF-7 and HGC-27 cell proliferation and metastasis. B09 significantly inhibited tumor growth in xenograft mice model with HGC-27 cells, showing decreased VEGF expression analyzed through immunohistochemistry.
Conclusion
B09 could specifically regulate VEGF gene expression, possibly through interacting with promoter i-motif structure. As a lead compound, B09 could be further developed for innovative anti-cancer agent targeting VEGF.
期刊介绍:
BBA General Subjects accepts for submission either original, hypothesis-driven studies or reviews covering subjects in biochemistry and biophysics that are considered to have general interest for a wide audience. Manuscripts with interdisciplinary approaches are especially encouraged.